NRIX stock

Nurix Therapeutics Inc (NRIX) financials · rev $84.0M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Nurix Therapeutics Inc (NRIX) rev $84.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$84.0M$54.5M
Operating Income-$285.7M-$213.0M
Net Income-$264.5M-$193.6M
EPS (Diluted)-$3.05-$2.88
Cached annual balance sheet
LineFY2025FY2024
Total Assets$688.1M$669.3M
Current Assets$606.8M$619.4M
Cash & Equivalents$247.0M$110.0M
PP&E$22.5M$17.8M
Total Liabilities$149.4M$142.3M
Current Liabilities$86.5M$95.9M
Shareholders' Equity$538.7M$527.0M
Retained Earnings-$1.00B-$738.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$249.5M-$172.6M
CapEx$14.0M$9.27M
Investing Cash Flow$147.9M-$257.7M
Financing Cash Flow$238.6M$485.7M
Net Change in Cash$137.0M$55.4M
Free Cash Flow-$263.5M-$181.9M
These statements as JSON? API free 100/day

FAQ

What is NRIX P/E and revenue?

Nurix Therapeutics Inc (NRIX) rev $84.0M.

What is NRIX revenue?

Nurix Therapeutics Inc last cached revenue is $84.0M (FY2025).

Is NRIX profitable?

Nurix Therapeutics Inc last cached net income is -$264.5M (FY2025).

What are NRIX total assets?

Nurix Therapeutics Inc last cached total assets are $688.1M (FY2025).

What is NRIX free cash flow?

Nurix Therapeutics Inc last cached free cash flow is -$263.5M (FY2025).

Not investment advice. Cached statements, not a live tape.